Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "distribution"

571 News Found

Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables
R&D | April 15, 2026

Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables

Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users


Unichem’s US arm recalls Buspirone tablets after stability test OOS result
News | April 13, 2026

Unichem’s US arm recalls Buspirone tablets after stability test OOS result

No adverse events reported; recall involves 5 mg 500-count bottles in the US market


EMA gives green light to warmer & simpler delivery rules for Wegovy injection
News | April 12, 2026

EMA gives green light to warmer & simpler delivery rules for Wegovy injection

Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio


CSIR-HRDC hosts intensive workshop on AI-driven drug discovery for scientists
Digitisation | April 10, 2026

CSIR-HRDC hosts intensive workshop on AI-driven drug discovery for scientists

Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise


India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters
Drug Approval | April 09, 2026

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga


Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail
News | April 05, 2026

Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail

The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores


Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib
Drug Approval | April 04, 2026

Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib

ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA


Rusan unveils APOSAN 3ml multi-dose pen
News | April 01, 2026

Rusan unveils APOSAN 3ml multi-dose pen

The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes


Corona Remedies acquires antiseptic brand Wokadine from Dr Reddy’s to enter Iodine market
News | March 31, 2026

Corona Remedies acquires antiseptic brand Wokadine from Dr Reddy’s to enter Iodine market

This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility


CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG
News | March 27, 2026

CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG

STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories